Synergistic antitumor effect of HMGB2 targeting combined with MDM2 inhibitor in diffuse intrinsic pontine glioma therapy
Bochao Zhang, Yuxuan Deng, Luyang Xie, Yiying Mai, Hang Zhou, Liwei Zhang · 2026
Read Synergistic antitumor effect of HMGB2 targeting combined with MDM2 inhibitor in diffuse intrinsic pontine glioma therapy by Bochao Zhang, Yuxuan Deng, Luyang Xie, Yiying Mai, Hang Zhou, Liwei Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619370.txt.
Description
Bochao Zhang and five co-authors test a drug pairing against a childhood brain tumor in a 2026 study. The tumor grows in the brainstem and has a bleak outlook. A chromatin protein that is high in these tumor cells acts like a cancer driver here. Lowering it slowed tumor growth and pushed cells to die, while normal precursor cells carried little of it.
Gene scans showed lowering the protein raised the level and activity of a famous tumor suppressor pathway. Pairing a blocker of the protein with a drug that frees that suppressor from its brake suppressed growth more than either alone. In mice the pairing shrank tumors and extended survival.
Catalog record
| CREATOR | Bochao Zhang, Yuxuan Deng, Luyang Xie, Yiying Mai, Hang Zhou, Liwei Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |